Searched for
EISAI GLENMARK
Glenmark launches generic cancer treatment drug in USGlenmark Pharmaceuticals on Tuesday launched Eribulin Mesylate Injection, a generic cancer treatment, in the US through its subsidiary Glen...- Glenmark Pharma launches anti-epileptic drug, Rufinamide, in the USThe newly launched drug is a therapeutic equivalent of Banzel tablets, 200 mg and 400 mg of Eisai, Inc. Banzel tablets are used in combinat...
- Glenmark gets final nod by USFDA to sell Rufinamide drugRufinamide is used to treat seizures caused by Lennox-Gastaut syndrome, it will be available as tablets in 200 mg and 400 mg strengths.
- Glenmark gets tentative USFDA nod to sell RufinamideGlenmark Pharmaceuticals today said it has been granted tentative approval by the US health regulator to sell Rufinamide.
Load More